AG0035YD

2058-46-0 | Oxytetracycline hydrochloride

Chemical structure of Oxytetracycline hydrochloride, CAS 2058-46-0
AG0035YD
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 2058-46-0
Catalog Number AG0035YD(AGN-PC-0QVMV9)
Chemical Name Oxytetracycline hydrochloride
EC Number 218-161-2
IUPAC Name (4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
InChI InChI=1S/C22H24N2O9.ClH/c1-21(32)7-5-4-6-8(25)9(7)15(26)10-12(21)17(28)13-14(24(2)3)16(27)11(20(23)31)19(30)22(13,33)18(10)29;/h4-6,12-14,17,25-26,28,30,32-33H,1-3H3,(H2,23,31);1H/t12-,13-,14+,17+,21-,22+;/m1./s1
InChI Key SVDOODSCHVSYEK-IFLJXUKPSA-N
MDL Number MFCD00135815
Molecular Formula C22H25ClN2O9
Molecular Weight 496.8949
NSC Number 757262
SMILES O[C@@]12[C@@H]([C@@H](O)[C@H]3C(=C1O)C(=O)c1c([C@@]3(C)O)cccc1O)[C@H](N(C)C)C(=C(C2=O)C(=O)N)O.Cl
UNII 4U7K4N52ZM
Synonyms
Bisolvomycin, Geomycin, Hydroxytetracycline, Oxyterracin, Oxyterracine, Oxytetracid, Oxytetracycline, Oxytetracycline Anhydrous, Oxytetracycline Calcium, Oxytetracycline Dihydrate, Oxytetracycline Hydrochloride, Oxytetracycline Monohydrochloride, Oxytetracycline Sulfate (2:1), Oxytetracycline, (4a beta,5 beta,5a beta,12a beta)-Isomer, Oxytetracycline, (5 beta)-Isomer, Oxytetracycline, Anhydrous, Oxytetracycline, Calcium (1:1) Salt, Oxytetracycline, Disodium Salt, Dihydrate, Oxytetracycline, Sodium Salt, Terramycin, OXYTETRACYCLINE HYDROCHLORIDE, Oxytetracycline HCl, 2058-46-0, Biosolvomycin, Dalinmycin, Engemycin, Oxamycen, Terramycin hydrochloride, Dalimycin, Unimycin, Liquamycin injectable, Chrysocin, Elinton, Intaloxin, Liquachel, Macodyn, Otetryn, Oxlopar, Oxyject, Oxytetral, Oxytetrin, Oxytracyl, Terraject, Toxinal, Biotet, Oxytet, Oxyvet, Oxy-Dumocyclin, Tetra-Tablinen, Oxy-Terachel, Bi Steclin, Ia-Loxin, Oxy-Rivo, Uri-Tet, Oxytetracycline.HCl, Imperacin, Mepatar, Oxacycline, Oxymykoin, Oxysteclin, Stecsolin, Stevacin, Vendarcin, Oxy WS, Oxydon, Oxyject 100, Bisolvomycin, Alamycin, Caswell No. 628, Oxy-Kesso-tetra, Oxy-Tet 50, Tetracycline, 5-oxy-, OXY-WS, Oxy-DE 250, Hydroxytetrazyklinhydrochlorid, UNII-4U7K4N52ZM, Aquacycline, Oxybiocycline, Oxytetracyclini hydrochloridum, Abbocin, Oxatets, Oxycycline, 5-Hydroxytetracycline monohydrochloride, CCRIS 200, TM 5 (VAN), EINECS 218-161-2, 5-Hydroxytetracycline hydrochloride, EPA Pesticide Chemical Code 006308, TM 5, component of Terramycin Topical Ointment, C22H24N2O9.HCl, AI3-50164, 4U7K4N52ZM, Oxytetracycline hydrochloride (internal use), CHEBI:31953, NCGC00091268-01, Terramycin (TN), NSC 9169, DSSTox_CID_1097, DSSTox_RID_75939, DSSTox_GSID_21097, (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S,4aR,5S,5aR,6S,12aS)-, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha))-, 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride, Oxatet, (4S,5S,6S,12aS,4aR,5aR)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl -1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide, chloride, CAS-2058-46-0, bisolvomyci n, Neo-oxy 100/100 MR, 5-Oxyetracycline, (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha)]-, AC1NWAPI, Oxytetracycline hydrochloride [USP:JAN], Oxytetracycline hydrochloride [USAN:JAN], AC1NR4G1, SCHEMBL124996, SPECTRUM1500457, Oxytetracycline Monohydrochloride, CHEMBL1607480, DTXSID5021097, HMS1920F04, Pharmakon1600-01500457, Hydroxytetracycline monohydrochloride, Tox21_111109, Tox21_201850, Tox21_300601, CCG-40206, LS-993, MFCD00135815, NSC757262, AKOS015950811, MCULE-3329146897, NC00526, NSC-757262, NCGC00164443-01, NCGC00254367-01, NCGC00259399-01, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, AC-11614, AN-19823, CPD001614498, Oxytetracycline hydrochloride (JP17/USP), SAM002554919, ST067106, AB0011435, AB1004856, O0475, OTC, C13055, D01596, C-22923, Oxytetracycline hydrochloride, >=95% (HPLC), crystalline, Oxytetracycline hydrochloride, can be used as secondary standard, Oxytetracycline hydrochloride, can be used as secondary standard, Oxytetracycline hydrochloride, can be used as secondary standard', Oxytetracycline hydrochloride, VETRANAL(TM), analytical standard, Oxytetracycline hydrochloride, European Pharmacopoeia (EP) Reference Standard, Oxytetracycline hydrochloride, United States Pharmacopeia (USP) Reference Standard, (2E,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione hydrochloride, (2Z,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione hydrochloride, (2Z,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione hydrochloride, (4S,5R,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride, 4- (dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride, Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-he xahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha))-, Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha))-, Oxytetracycline Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, oxytetracycline, Terramycin, Hydrocyclin, Berkmycen, Oxymycin, Terra-cortril, Medamycin, Medemycin, Tetramine, Tetran hydrochloride, Urobiotic-250, Mixture Name, Oxytetracyclinehydrochloride, TERRAMYCIN-POLYMYXIN, C22H24N2O9.ClH, TERRAMYCIN W/ POLYMYXIN, Oxytetracycline hydrochloride [JAN], C22-H24-N2-O9.Cl-H, Oxytetracycline HCL & injection grage, CID5284437, CID5702102, CS-O-02009, TERRAMYCIN W/ POLYMYXIN B SULFATE, Oxytetracycline hydrochloride, 97% - 1G 1g, 2-Naftacenocarboxamida, 4-(dimetilamino)-1,4,4 a, 5,5 a, 6,11,12 a-octahidro-3, 5,6,10,12,12 a-hexahidroxi-6-metil-1, 11-dioxo-, clorhidrato (1:1), (4S, 4aR, 5S, 5aR, 6S, 12aS)-, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, hydrochloride (1:1), (4S,4aR,5S,5aR,6S,12aS)-, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.,6.beta.,12a.alpha.)]-, 6153-64-6,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited